Weight-Loss Surgery Creates High Rate of Anemia
|
By HospiMedica International staff writers Posted on 03 Oct 2017 |
|
Image: A new study Roux-en-Y gastric bypass bariatric surgery can lead to anemia (Photo courtesy of Alamy).
A new long-term study reports a high rate of anemia 10 years after patients receive Roux-en-Y gastric bypass (RYGB) bariatric surgery.
Researchers at Palo Alto Veterans Affairs (VA) Health Care System (CA, USA) and Stanford University (Stanford; CA, USA) conducted a study that involved 74 patients (78% men; average age 51 years) who underwent RYGB at the Palo Alto VA Medical Center and survived to 10-year follow-up. Mean BMI before the procedure was 46.1 kg/m2, and ten years later it stood at 33.7 kg/m2.
The average rate of preoperative anemia was 20%, which increased 10 years later to 47%. During the same time period, the anemia rate in the RYGB group without bariatric specialist follow-up increased to 57% percent, from 22% before surgery. The rate of anemia in those with bariatric specialist follow-up did not increase as significantly 10 years after surgery, rising from 13% preoperatively to 19% at 10 years, after adjusting for preoperative anemia. The study was published on September 20, 2017, in JAMA Surgery.
“Our study suggests that follow-up with bariatric specialists more than five years after surgery, rather than with specialists with no bariatric expertise, can decrease long-term anemia risk,” concluded senior author Dan Eisenberg, MD, MSc, of Stanford. “This finding may demonstrate the bariatric specialist's specific understanding of the long-term risk for nutritional deficiency after RYGB, and the importance of vitamin and mineral supplementation.”
The RYGB procedure has been the gold standard for surgical weight loss intervention for many years. The procedure usually involves laparoscopic minimally invasive surgery to create a stomach pouch from the larger stomach body, which is then connected to a section of the small intestine, leaving just a small opening for food. The result is a rapid sensation of satiety or fullness. Various medical, nutritional, and surgical symptoms requiring treatment may occur after RYGB surgery and may impair patients' quality of life.
Related Links:
Palo Alto Veterans Affairs
Stanford University
Researchers at Palo Alto Veterans Affairs (VA) Health Care System (CA, USA) and Stanford University (Stanford; CA, USA) conducted a study that involved 74 patients (78% men; average age 51 years) who underwent RYGB at the Palo Alto VA Medical Center and survived to 10-year follow-up. Mean BMI before the procedure was 46.1 kg/m2, and ten years later it stood at 33.7 kg/m2.
The average rate of preoperative anemia was 20%, which increased 10 years later to 47%. During the same time period, the anemia rate in the RYGB group without bariatric specialist follow-up increased to 57% percent, from 22% before surgery. The rate of anemia in those with bariatric specialist follow-up did not increase as significantly 10 years after surgery, rising from 13% preoperatively to 19% at 10 years, after adjusting for preoperative anemia. The study was published on September 20, 2017, in JAMA Surgery.
“Our study suggests that follow-up with bariatric specialists more than five years after surgery, rather than with specialists with no bariatric expertise, can decrease long-term anemia risk,” concluded senior author Dan Eisenberg, MD, MSc, of Stanford. “This finding may demonstrate the bariatric specialist's specific understanding of the long-term risk for nutritional deficiency after RYGB, and the importance of vitamin and mineral supplementation.”
The RYGB procedure has been the gold standard for surgical weight loss intervention for many years. The procedure usually involves laparoscopic minimally invasive surgery to create a stomach pouch from the larger stomach body, which is then connected to a section of the small intestine, leaving just a small opening for food. The result is a rapid sensation of satiety or fullness. Various medical, nutritional, and surgical symptoms requiring treatment may occur after RYGB surgery and may impair patients' quality of life.
Related Links:
Palo Alto Veterans Affairs
Stanford University
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Mammography System (Analog)
MAM VENUS
New
Ureteral Dilatation Balloon
Dornier Equinox
Latest Surgical Techniques News
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
- Ultrasound-Activated Microstructures Clean Implanted Stents and Catheters
- First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment
- Bioprinted Aortas Offer New Hope for Vascular Repair
Channels
Critical Care
view channel
Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
Spinal cord injuries remain incurable and can have life-altering consequences. These injuries disrupt the communication pathway between the brain and the body, often leading to permanent loss of function.... Read more
Smart Capsule Offers Real-Time Profiling Across GI Tract
Researchers are increasingly recognizing the gastrointestinal (GI) tract as a key player in overall health. While its primary role is in digestion, the GI tract also contributes to the production of hormones,... Read more
Patient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read more
Business
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
